stigmasterol - CISMeF

Preferred Label : stigmasterol;

MeSH synonym : poriferasterol;

CISMeF synonym : stigmasta-5,22-dien-3-.beta.-ol;

MeSH CAS label : Stigmasta-5,22-dien-3-ol, (3beta,22E)-;

MeSH Related Number : 83-48-7 (Stigmasterol);

Registry Number MeSH : 83-48-7;

MeSH annotation : called anti-stiffness factor;

Wikipedia link : https://en.wikipedia.org/wiki/Stigmasterol;

Codes EINECS : 201-482-7;

Is substance : O;

UNII : 99WUK5D0Y8;

InChIKey : HCXVJBMSMIARIN-PHZDYDNGSA-N;

Details

Origin ID

D013265;

UMLS CUI

C0038329;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- stigmasta-5,22-dien-3-.beta.-ol [Substance BNPC]
Currated CISMeF NLP mapping
- Stigmasterol [LOINC component]
- Stigmasterol [NCIt concept]
- Stigmasterol (substance) [SNOMED CT concept]
Record concept(s)
- stigmasterol [MeSH concept]
Related MeSH Supplementary Concept(s)
- (24R)-5-stigmast-9-(11)-en-3beta-D-glucopyranoside [MeSH Supplementary Concept]
- (24R)stigmast-1,5-dien-3 beta-ol [MeSH Supplementary Concept]
- 1,2-distigmasterylhemisuccinoyl-glycero-3-phosphocholine [MeSH Supplementary Concept]
- 12-hydroxystigmast-4-en-3-one [MeSH Supplementary Concept]
- 14,15,18,20-diepoxyturbinarin [MeSH Supplementary Concept]
- 22,23-dihydrospinasterone [MeSH Supplementary Concept]
- 22,23-dihydroxystigmast-4-en-3-one [MeSH Supplementary Concept]
- 23a-homostigmast-5-en-3beta-ol [MeSH Supplementary Concept]
- 24(24')-dehydroamarasterone B [MeSH Supplementary Concept]
- 24-hydroperoxy-24-vinylcholesterol [MeSH Supplementary Concept]
- 25,28-dimethylstigmasta-5,22,28-trien-3beta-ol [MeSH Supplementary Concept]
- 25,28-dimethylstigmasta-5,28-dien-3beta-ol [MeSH Supplementary Concept]
- 29-fluorostigmasterol [MeSH Supplementary Concept]
- 3,29-dihydroxystigmast-5-ene-3-O-galactopyranoside [MeSH Supplementary Concept]
- 3,5,22,23-tetrahydroxystigmastan-6-one [MeSH Supplementary Concept]
- 3,6,17-trihydroxy-stigmasta-4,7,24(28)-triene [MeSH Supplementary Concept]
- 3-O-(6'-O-palmitoylglucosyl)stigmasta-5,25(27)-diene [MeSH Supplementary Concept]
- 3-O-(6'-O-stearoylglucosyl)stigmasta-5,25(27)-diene [MeSH Supplementary Concept]
- 3-O-beta-D-glucopyranosyl-spinasterol [MeSH Supplementary Concept]
- 3-hydroxystigmast-5-en-7-one [MeSH Supplementary Concept]
- 3beta-stigmast-5-en-3-ol butyl tridecanedioate [MeSH Supplementary Concept]
- 4',5'-dimethoxybenzoyloxystigmasterol [MeSH Supplementary Concept]
- 6-chlorostigmasterol [MeSH Supplementary Concept]
- 7-dehydrostigmasterol [MeSH Supplementary Concept]
- 7-ketostigmasterol [MeSH Supplementary Concept]
- amarasterone A [MeSH Supplementary Concept]
- blattellastanoside A [MeSH Supplementary Concept]
- cyasterone [MeSH Supplementary Concept]
- dehydroogoniol [MeSH Supplementary Concept]
- foetidin [MeSH Supplementary Concept]
- fucosterol [MeSH Supplementary Concept]
- fucosterol epoxide [MeSH Supplementary Concept]
- itesmol 3-O-palmitate [MeSH Supplementary Concept]
- poriferasterol monoglucoside [MeSH Supplementary Concept]
- saringosterol [MeSH Supplementary Concept]
- saringosterone [MeSH Supplementary Concept]
- schottenol glucoside [MeSH Supplementary Concept]
- spinasterol [MeSH Supplementary Concept]
- stigmast-4,20(21),23-trien-3-one [MeSH Supplementary Concept]
- stigmast-4-en-3-one [MeSH Supplementary Concept]
- stigmast-4-ene-1,3-dione [MeSH Supplementary Concept]
- stigmast-5-en-3 beta,24-diol [MeSH Supplementary Concept]
- stigmast-5-en-3beta,7beta-diol [MeSH Supplementary Concept]
- stigmast-5-en-3beta-ol-3-O-beta-D-(2'-n-triacontanoyl)glucopyranoside [MeSH Supplementary Concept]
- stigmast-5-ene 3,4,7,22-tetraol [MeSH Supplementary Concept]
- stigmast-5-ene 3,7,22-triol [MeSH Supplementary Concept]
- stigmast-5-ene-3 beta,28-diol [MeSH Supplementary Concept]
- stigmast-5-ene-3beta,17-diol [MeSH Supplementary Concept]
- stigmasta-5,22-dien-3-ol [MeSH Supplementary Concept]
- stigmasta-5,7,14,22,25-pentaene-3-ol [MeSH Supplementary Concept]
- stigmasta-5,7,22,25-tetraene-3-ol [MeSH Supplementary Concept]
- stigmasta-7,22,25-triene-3-nonadecanoic acid ester [MeSH Supplementary Concept]
- stigmasterol 3-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- stigmasterol glucoside [MeSH Supplementary Concept]
- stigmasterol-24,28-epoxide [MeSH Supplementary Concept]
- stigmasteryl 3-O-glucoside 6'-O-palmitate [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Stigmasterol [LOINC component]
- Stigmasterol [NCIt concept]
- Stigmasterol (substance) [SNOMED CT concept]
- stigmasta-5,22-dien-3-.beta.-ol [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients